This study did not find a benefit associated with vitamin D supplementation in COVID-19 patients but did identify that vitamin D deficiency may be a risk factor for higher in-patient mortality.
In this prospective study, the self-reported use of vitamin D supplements was associated with a lower risk of COVID-19 infection, independent of lifestyle, socio-economic status, prevalent chronic diseases and circulating...
Results from this retrospective analysis demonstrate that two consecutive doses of 200,000 IU cholecalciferol (total of 400,000 IU) can significantly improve the outcome in patients affected by COVID-19 that are also burdened with three or more...
In this observational study, treatment with cholecalciferol booster therapy, regardless of baseline serum 25(OH)D levels, appears to be associated with a reduced risk of mortality in acute in-patients admitted with COVID-19.
In this 40 person randomized, placebo-controlled study in India a greater proportion of vitamin D-deficient individuals with mildly symptomatic COVID-19 infections tested COVID-19 negative...
